Illuminating Optimal CAR T-Cell Therapies Across Large B-Cell Lymphoma Groups
Cancer Network,
CAR T-cell therapy has emerged as a viable treatment for patients with diffuse large B-cell lymphoma (DLBCL), offering…
CAR T-cell therapy has emerged as a viable treatment for patients with diffuse large B-cell lymphoma (DLBCL), offering…
In this Satellite Session, experts convened to discuss CAR T-cell candidacy among patients across a range of large B-cell…
Cytotoxic T cells play a vital role in the body’s immune defense against tumors.
- First SMC acceptance of any CAR T-cell therapy for lymphoma patients in the second-line setting - - Axi-cel is now available…